Graphy
South Korean developer of 3D-printable shape memory clear aligners and photopolymer resins for dental and medical applications.
- CEO / Founder
- Sim Un-seob (심운섭)
- Team Size
- 51-200
- Stage
- Public
- Total Funding
- $24.5M
- Latest Round
- Series C
- Key Investors
- Gene & Partners; Heungkuk Securities; KB Securities; Hyundai Investment Partners; Axis Investment; Openwater Investment; Hanbit Investment
Technology & Products
Key Products
Tera Harz Clear (direct 3D-printable shape memory aligner resin); Tera Harz series photopolymer resins for dental guides, mouthguards, and prosthetics; S Plastic high-functional resins; 3D printing hardware and software solutions for digital dentistry.
Technological Advantage
Proprietary oligomer synthesis technology for shape memory photopolymer resins; vertically integrated material+hardware+software platform; FDA-cleared, CE-marked, and PMDA-approved materials; 35+ registered patents.
Differentiation
Value Proposition
World's first directly 3D-printable shape memory clear aligner (SMA) technology using proprietary photopolymer resin, eliminating traditional thermoforming steps in orthodontic appliance fabrication.
How They Differentiate
Only company offering direct 3D-printed shape memory aligners without thermoforming; vertically integrated material chemistry + printer + software; shape memory property provides sustained force and better fit vs. traditional thermoformed aligners.
Market & Competition
Target Customers
Orthodontic practices, dental labs, and dental clinics worldwide; also 3D printer manufacturers and material distributors.
Industry Verticals
Dental/Orthodontics, Medical Devices, Digital Healthcare
Competitors
Align Technology (Invisalign); Stratasys Direct; 3D Systems (dental segment)
Growth & Milestones
Growth Metrics
2024 revenue: ₩16.14B (~$12M); ~80% of revenue from overseas markets (Japan, Italy, Germany, etc.); ~124 employees (as of April 2026)
Major Milestones
2017: Company founded; 2021: World's first direct 3D-printed aligner resin (Tera Harz) launched; 2023: Series C funding of ₩15B; 2024: FDA clearance for clear aligner material; 2025-08: KOSDAQ listing (ticker 318060); 2025: Exclusive strategic partnership with FUGO for mass production of SMA; 2025: Partnership with Medit for workflow integration.
Notable Customers
2,000+ orthodontists globally; Dr. Kenji Ojima (Japan); Dr. Ravindra Nanda (University of Connecticut); FUGO Precision 3D
Recent coverage of Graphy
- Graphy in discussions with Megagen for comprehensive 3D printing dental materials partnership
- Graphy and KAIST publish cellulose nanocrystal medical device material study, boosting resin tensile strength by 173%
- Grapy publishes joint research with KAIST in international journal on next-gen 3D printing medical materials
- Graphy targets North American market with SMA 3D-printed clear aligner at AAO 2026
- Graphy unveils Tera Harz Wide Cure and SMA Portal at AAO 2026, targets North American aligner market